Robert Kerwin

12.7k total citations
216 papers, 9.2k citations indexed

About

Robert Kerwin is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Robert Kerwin has authored 216 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Psychiatry and Mental health, 89 papers in Cellular and Molecular Neuroscience and 62 papers in Molecular Biology. Recurrent topics in Robert Kerwin's work include Schizophrenia research and treatment (88 papers), Neurotransmitter Receptor Influence on Behavior (48 papers) and Receptor Mechanisms and Signaling (42 papers). Robert Kerwin is often cited by papers focused on Schizophrenia research and treatment (88 papers), Neurotransmitter Receptor Influence on Behavior (48 papers) and Receptor Mechanisms and Signaling (42 papers). Robert Kerwin collaborates with scholars based in United Kingdom, United States and Germany. Robert Kerwin's co-authors include C Pycock, Lyn S. Pilowsky, Christopher Carter, María J. Arranz, Robin Murray, Janet Munro, Andrew Makoff, Durval C. Costa, David Collier and Paul J. Harrison and has published in prestigious journals such as Nature, The Lancet and Nature Medicine.

In The Last Decade

Robert Kerwin

210 papers receiving 8.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Kerwin United Kingdom	54	3.7k	3.6k	2.4k	1.6k	1.1k	216	9.2k
Nakao Iwata Japan	52	3.0k 0.8×	3.0k 0.8×	3.3k 1.4×	1.5k 0.9×	2.1k 2.0×	482	11.4k
Mika Scheinin Finland	65	1.9k 0.5×	4.4k 1.2×	4.1k 1.7×	1.2k 0.7×	366 0.3×	389	15.3k
Robert A. Sweet United States	58	4.2k 1.1×	1.9k 0.5×	2.0k 0.8×	1.9k 1.1×	820 0.7×	246	9.8k
I. Nicol Ferrier United Kingdom	41	2.5k 0.7×	1.3k 0.4×	931 0.4×	1.0k 0.6×	262 0.2×	112	6.3k
Paul G. Ince United Kingdom	80	3.7k 1.0×	3.7k 1.0×	5.5k 2.3×	1.2k 0.7×	499 0.5×	295	21.7k
Cristina Colombo Italy	54	3.2k 0.9×	1.0k 0.3×	610 0.3×	2.5k 1.5×	627 0.6×	245	8.8k
Peter Thorén Sweden	60	759 0.2×	2.6k 0.7×	2.4k 1.0×	696 0.4×	669 0.6×	199	11.5k
Michael Mullan United States	64	2.2k 0.6×	2.1k 0.6×	5.5k 2.3×	569 0.3×	738 0.7×	319	15.3k
Mónica Di Luca Italy	62	1.8k 0.5×	5.0k 1.4×	3.7k 1.5×	1.1k 0.7×	501 0.5×	233	11.6k
Stanley Berent United States	44	3.2k 0.9×	1.4k 0.4×	639 0.3×	1.9k 1.2×	219 0.2×	114	7.8k

Countries citing papers authored by Robert Kerwin

Since Specialization

Citations

This map shows the geographic impact of Robert Kerwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Kerwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Kerwin more than expected).

Fields of papers citing papers by Robert Kerwin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Kerwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Kerwin. The network helps show where Robert Kerwin may publish in the future.

Co-authorship network of co-authors of Robert Kerwin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Kerwin. A scholar is included among the top collaborators of Robert Kerwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Kerwin. Robert Kerwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yau, Joyce L.W., June Noble, Sarah Thomas, et al.. (2007). The Antidepressant Desipramine Requires the ABCB1 (Mdr1)-Type p-Glycoprotein to Upregulate the Glucocorticoid Receptor in Mice. Neuropsychopharmacology. 32(12). 2520–2529. 42 indexed citations

Taylor, David, Karen P. Hayhurst, & Robert Kerwin. (2007). A controlled, mirror-image study of second-generation antipsychotics in the treatment of schizophrenia. International Clinical Psychopharmacology. 22(3). 133–136. 4 indexed citations

Lewis, Shôn, Linda Davies, Peter B. Jones, et al.. (2006). Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Health Technology Assessment. 10(17). iii–iv, ix. 184 indexed citations

Wolff, Kim, Patricia Huezo-Diaz, Adam Winstock, et al.. (2006). Positive association of CYP2D6 and COMT variants with ecstasy-induced changes in water homeostatic measures. American Journal of Medical Genetics Part A. 789–789. 2 indexed citations

Basu, Anupam, et al.. (2004). An association study of the CYP1A2 C-164A and T-3591G polymorphisms and response to clozapine. Schizophrenia Research. 67(1). 52–52. 1 indexed citations

Mundo, Emanuela, Maria Neves-Pereira, Erin Dalton, et al.. (2003). Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Molecular Psychiatry. 8(2). 241–245. 88 indexed citations

Arranz, María J. & Robert Kerwin. (2003). Advances in the pharmacogenetic prediction of antipsychotic response. Toxicology. 192(1). 33–35. 10 indexed citations

Meagher, Dennis M., et al.. (2002). Association study of the CYP1A2 C(164)A polymorphism and tardive dyskinesia (TD). Schizophrenia Research. 53(3). 75–75. 1 indexed citations

Bolonna, A. A., Robert Kerwin, Janet Munro, María J. Arranz, & Andrew Makoff. (2001). Polymorphisms in the genes for mGluR types 7 and 8: association studies with schizophrenia. Schizophrenia Research. 47(1). 99–103. 33 indexed citations

10.

Matthíasson, Páll, Dimitris Visvikis, Durval C. Costa, et al.. (2001). Decreased dopamine D2 receptor binding potential in the basal ganglia after augmenting clozapine treatment with amisulpride: A 123-I-IBZM SPET-study. Schizophrenia Research. 49. 194–195. 2 indexed citations

11.

Pariante, Carmine M., Andrew Makoff, Simon Lovestone, et al.. (2001). Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. British Journal of Pharmacology. 134(6). 1335–1343. 136 indexed citations

12.

Birkett, Joseph, et al.. (2000). Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response. Neuroreport. 11(9). 2017–2020. 73 indexed citations

13.

Stefanis, Nicholas C., Janine Bresnick, Robert Kerwin, William Schofield, & George McAllister. (1998). Elevation of D4 dopamine receptor mRNA in postmortem schizophrenic brain. Molecular Brain Research. 53(1-2). 112–119. 52 indexed citations

14.

Cotter, David, Robert Kerwin, Jean‐Pierre Brion, et al.. (1998). Abnormalities of Wnt signalling in schizophrenia – evidence for neurodevelopmental abnormality. Neuroreport. 9(7). 1379–1383. 128 indexed citations

15.

Busatto, Geraldo F., Lyn S. Pilowsky, Durval C. Costa, et al.. (1997). Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia [published erratum appears in Am J Psychiatry 1997 May;154(5):722]. American Journal of Psychiatry. 154(1). 56–63. 75 indexed citations

16.

Busatto, Geraldo F., Lyn S. Pilowsky, Durval C. Costa, et al.. (1997). Initial evaluation of123|-5-|-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects. European Journal of Nuclear Medicine and Molecular Imaging. 24(2). 119–124. 28 indexed citations

17.

Pilowsky, Lyn S., P. O’Connell, Nathan Davies, et al.. (1997). In vivo effects on striatal dopamine D 2 receptor binding by the novel atypical antipsychotic drug sertindole - a 123 I IBZM single photon emission tomography (SPET) study. Psychopharmacology. 130(2). 152–158. 31 indexed citations

18.

Curtis, Vivienne & Robert Kerwin. (1995). A Risk-Benefit Assessment of Risperidone in Schizophrenia. Drug Safety. 12(2). 139–145. 19 indexed citations

19.

Busatto, Geraldo F., Durval C. Costa, Peter J. Ell, et al.. (1994). Regional cerebral blood flow (rCBF) in schizophrenia during verbal memory activation: a ^99mTc-HMPAO single photon emission tomography (SPET) study. Psychological Medicine. 24(2). 463–472. 30 indexed citations

20.

Harrison, Paul J., Daniel P. McLaughlin, & Robert Kerwin. (1991). Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. The Lancet. 337(8739). 450–452. 194 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact